SNN earnings: real EPS beat/miss history, analyst consensus Hold, P/E 20.11. Updated 2026-07-23.
Smith & Nephew (SNN) Research Hub
Smith & Nephew (SNN) trades on NYSE, GB in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 27.5 USD (-1.08%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 20.11, market cap 12.61B. This hub links to the full technical, earnings and options research available for SNN.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NYSE, GB |
| Last close | 27.5 USD (-1.08%) |
| 52-week range | 27.23 USD – 32.76 USD |
| Trend regime | Range |
| 14-day RSI | 10.8 (Oversold) |
| Trailing P/E | 20.11 |
| Market cap | 12.61B |
| Dividend yield | 2.61% |
Available research for SNN
Covered Call on SNN: how it works, illustrative setup around the real 27.5 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SNN: how it works, illustrative setup around the real 27.5 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SNN: how it works, illustrative setup around the real 27.5 USD price, max profit/loss, breakeven and when to use it. Educational.
SNN technical analysis: range, last 27.5 USD, RSI 10.8, 52w range 27.23 USD–32.76 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is SNN in?
Smith & Nephew (SNN) is classified under Healthcare (Medical - Devices), listed on NYSE, GB.
Is SNN in an uptrend or downtrend?
As of 2026-09-11, SNN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SNN's trailing P/E ratio?
SNN's trailing P/E is 20.11, with a market cap of 12.61B. See the earnings research page for full valuation detail.